nicotinamide mononucleotide has been researched along with Innate Inflammatory Response in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 9 (81.82) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; He, B; Huang, R; Wan, Y; Wang, C; Wang, L; Zhu, D; Zhu, J | 1 |
| Chen, Y; Dai, X; Guo, F; Han, Z; Li, L; Li, Z; Wang, L; Wang, Z; Wei, J; Zhang, X; Zhu, H | 1 |
| Cai, W; Hu, C; Li, T; Ren, C; Shen, T; Wu, Y; Yu, D; Yu, J; Zou, A | 1 |
| Chen, H; Geng, XL; Li, GQ; Li, L; Li, ZB; Liu, LW; Lu, TQ; Shang, LR; Sui, YH; Sun, B; Wang, YW; Xie, Y; Xue, DB; Yang, WB; Zhang, T; Zhang, YY; Zhao, ZJ | 1 |
| Deng, XM; Li, HR; Li, P; Liu, Q; Tian, Y; Wang, JF; Zhu, CL | 1 |
| Imamura, H; Kitano, H; Kratz, A; Nishino, T; Sano, H; Shimizu, N; Yachie, A; Yoshida, Y | 1 |
| Cao, T; Ding, W; Fan, GC; Ji, X; Ni, R; Peng, T; Zhang, Z | 1 |
| Braidy, N; Liu, Y | 1 |
| Agorrody, G; Baker, DJ; Baur, JA; Chellappa, K; Childs, BG; Chini, CCS; Chini, EN; Clarke, S; Dang, K; De Cecco, M; de Oliveira, GC; Espindola-Netto, JM; Gomez, LS; Hogan, KA; Jankowski, C; Kanamori, KS; Kashyap, S; Kirkland, AL; Kirkland, JL; McReynolds, MR; Peclat, TR; Puranik, AS; Rabinowitz, JD; Sedivy, JM; Tarragó, MG; Tchkonia, T; Thompson, KL; van Deursen, JM; van Schooten, W; Vidal, P; Warner, GM; Witte, MA | 1 |
| Baur, JA; Botolin, P; Davila, A; Guan, Y; Mukherjee, S; Sims, CA; Singh, K | 1 |
| Caton, PW; Holness, MJ; Kieswich, J; Sugden, MC; Yaqoob, MM | 1 |
1 review(s) available for nicotinamide mononucleotide and Innate Inflammatory Response
| Article | Year |
|---|---|
NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis.
Topics: Aging; Animals; Humans; Inflammation; Mice; NAD; Neurodegenerative Diseases; Niacinamide; Nicotinamide Mononucleotide; Oxidative Stress; Pyridinium Compounds; Rats; Risk Assessment | 2020 |
10 other study(ies) available for nicotinamide mononucleotide and Innate Inflammatory Response
| Article | Year |
|---|---|
Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cardiotonic Agents; Cardiotoxicity; Doxorubicin; Fibrosis; Heart; Inflammasomes; Inflammation; Male; Myocardium; Nicotinamide Mononucleotide; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Rats, Sprague-Dawley; Ventricular Dysfunction, Left | 2021 |
Administration of nicotinamide mononucleotide improves oocyte quality of obese mice.
Topics: Actins; Animals; Diet, High-Fat; Female; Humans; Inflammation; Mice; Mice, Inbred C57BL; Mice, Obese; Nicotinamide Mononucleotide; Obesity; Oocytes; Pregnancy; Reactive Oxygen Species | 2022 |
Nicotinamide Mononucleotide Ameliorates Cellular Senescence and Inflammation Caused by Sodium Iodate in RPE.
Topics: Cellular Senescence; Humans; Inflammation; Iodates; Macular Degeneration; NAD; Nicotinamide Mononucleotide; Oxidative Stress; Retinal Pigment Epithelium | 2022 |
Gut microbiota-derived nicotinamide mononucleotide alleviates acute pancreatitis by activating pancreatic SIRT3 signalling.
Topics: Acute Disease; Animals; Ceruletide; Dysbiosis; Gastrointestinal Microbiome; Inflammation; Mice; NAD; Nicotinamide Mononucleotide; Pancreatitis; Rats; Sirtuin 3 | 2023 |
Nicotinamide Mononucleotide Attenuates LPS-Induced Acute Lung Injury With Anti-Inflammatory, Anti-Oxidative and Anti-Apoptotic Effects.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Inflammation; Interleukin-6; Lipopolysaccharides; Lung; Mice; NF-kappa B; Nicotinamide Mononucleotide; p38 Mitogen-Activated Protein Kinases; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2023 |
Nicotinamide mononucleotide (NMN) alleviates the poly(I:C)-induced inflammatory response in human primary cell cultures.
Topics: Bayes Theorem; Endothelial Cells; Humans; Inflammation; NAD; Nicotinamide Mononucleotide; Primary Cell Culture | 2023 |
Nicotinamide mononucleotide as a therapeutic agent to alleviate multi-organ failure in sepsis.
Topics: Animals; Endothelial Cells; Inflammation; Mice; Mitochondrial Diseases; NAD; Nicotinamide Mononucleotide; Sepsis; Sirtuin 3 | 2023 |
CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD
Topics: Adipocytes, White; Adipose Tissue, White; ADP-ribosyl Cyclase 1; Aging; Animals; Bone Marrow Transplantation; Cellular Senescence; HEK293 Cells; Humans; Inflammation; Liver; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; NAD; Nicotinamide Mononucleotide; Phenotype | 2020 |
Nicotinamide mononucleotide preserves mitochondrial function and increases survival in hemorrhagic shock.
Topics: Acidosis, Lactic; Adenosine Triphosphate; Animals; Cytokines; Hepatocytes; Humans; Inflammation; Interleukin-6; Kidney; Liver; Male; Mitochondria; Mitochondrial Diseases; NAD; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Nicotinamide-Nucleotide Adenylyltransferase; Rats; Resuscitation; Shock, Hemorrhagic; Survival Analysis | 2018 |
Nicotinamide mononucleotide protects against pro-inflammatory cytokine-mediated impairment of mouse islet function.
Topics: Animals; Cell Differentiation; Cells, Cultured; Cytokines; Fructose; Inflammation; Insulin; Insulin Secretion; Interleukin-1beta; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Sirtuin 1; Tumor Necrosis Factor-alpha | 2011 |